Getinge AB (publ)'s latest marketcap:
As of 08/11/2025, Getinge AB (publ)'s market capitalization has reached $5.62 B. According to our data, Getinge AB (publ) is the 3108th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 5.62 B |
| Revenue (ttm) | 3.7 B |
| Net Income (ttm) | 155.44 M |
| Shares Out | 272.37 M |
| EPS (ttm) | 0.57 |
| Forward PE | 18.10 |
| Ex-Dividend Date | 04/23/2025 |
| Earnings Date | 07/18/2025 |
Getinge AB (publ)'s yearly market capitalization.
| Date | Market Cap(kr) | Market Cap(USD) | Change (%) | Global Rank |
|---|---|---|---|---|
| 08/11/2025 | kr53.86 B | $5.62 B | 8.92% | 3108 |
| 12/30/2024 | kr49.45 B | $4.45 B | -19.06% | 3268 |
| 12/29/2023 | kr61.09 B | $6.02 B | 3.7% | 2476 |
| 12/30/2022 | kr58.91 B | $5.62 B | -45.25% | 2442 |
| 12/30/2021 | kr107.61 B | $11.84 B | 105.67% | 1582 |
| 12/30/2020 | kr52.32 B | $6.33 B | 10.4% | 2365 |
| 12/30/2019 | kr47.39 B | $5.04 B | 117.77% | 2364 |
| 12/28/2018 | kr21.76 B | $2.45 B | -32.86% | 3506 |
| 12/29/2017 | kr32.41 B | $3.94 B | -6.91% | 2814 |
| 12/30/2016 | kr34.82 B | $3.81 B | -34.34% | 2404 |
Company Profile
About Getinge AB (publ)
Getinge AB (publ) is a leading provider of medical technology solutions, specializing in products for operating rooms, intensive-care units, and sterilization departments. Headquartered in Gothenburg, Sweden, the company has a global presence, serving customers through sales companies, agents, and distributors across the Americas, Europe, the Middle East, Africa, and the Asia-Pacific region.
Business Segments
- Acute Care Therapies: Offers extracorporeal membrane oxygenation, mechanical ventilation, advanced patient monitoring, ICU infrastructure, and drainage solutions.
- Life Science: Provides bioreactor preparation, bioprocess development, labware cleaning and sterilization, biocontainment, and vivarium solutions.
- Surgical Workflows: Delivers surgical perfusion, endoscopic vessel harvesting, intra-aortic balloon counterpulsation, and operating room integration solutions.
Key Products & Solutions
- Sterilization & Infection Control: Pre-cleaning, disinfection, sterile supply management, and low-temperature sterilization.
- Surgical Equipment: Vascular and cardiothoracic surgery tools, peripheral stenting, and beating heart surgery devices.
- Connected Medical Devices: Patient flow management and advanced monitoring systems.
- Bioprocessing: Aseptic transfer, large-scale cultivation, and terminal sterilization technologies.
Founded in 1904, Getinge AB (publ) continues to innovate and expand its portfolio to meet the evolving needs of healthcare and life science industries worldwide.
Frequently Asked Questions
-
What is Getinge AB (publ)'s (STO-GETI.B) current market cap?As of 08/11/2025, Getinge AB (publ) (including the parent company, if applicable) has an estimated market capitalization of $5.62 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Getinge AB (publ) (STO-GETI.B) rank globally by market cap?Getinge AB (publ) global market capitalization ranking is approximately 3108 as of 08/11/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.